Incyte Corporation (INCY) - NASDAQ
From other sites
Company Description
Incyte Corp. is a biopharmaceutical company. It focuses on the discovery, development and commercialization of proprietary small molecule drugs to treat serious unmet medical needs. The company's product, Jakafi (ruxolitinib), a JAK1 and JAK2 inhibitor, is currently approved in the U.S. for the... More
Sector: Healthcare
Industry: Biotechnology
Country: United States